If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Email*

Password*

Keep me logged in Forgot your password?

Email*

Jody A. Charnow

Email Jody A. Charnow

Jody Charnow is the editor of Renal and Urology News.

Recent Articles

Novel Formulation Corrects Vitamin D, Lowers iPTH

May 13, 2012

NATIONAL HARBOR, Md.—An investigational treatment safely and effectively lowers elevated plasma intact parathyroid hormone (iPTH) levels in patients with stage 3 or 4 chronic kidney disease and vitamin D deficiency, researchers reported at the National Kidney Foundation 2012 Spring Clinical Meetings.

High, Low PTH Raises Hypercalcemia Risk

May 13, 2012

NATIONAL HARBOR, Md.—Low and high levels of parathyroid hormone (PTH) are associated with hypercalcemia, according to a study of 106,760 hemodialysis patients presented at the National Kidney Foundation 2012 Spring Clinical Meetings suggest.

Obesity a Barrier to Living Kidney Donation

May 13, 2012

NATIONAL HARBOR, Md.—Morbid obesity often is a barrier to living kidney donation, researchers reported at the National Kidney Foundation 2012 Spring Clinical Meetings.

Fluid Overload in Burn Patients Affects Survival

May 13, 2012

NATIONAL HARBOR, Md.—Fluid overload in adult burn patients is associated with increased mortality, data presented at the National Kidney Foundation 2012 Spring Clinical Meetings suggest.

Peginesatide Requirements Do Not Differ By Race

May 13, 2012

NATIONAL HARBOR, Md.—Black hemodialysis (HD) patients with anemia require relatively more epoetin than their non-black counterparts to achieve similar hemoglobin (Hb) levels, but blacks and non-blacks required similar peginesatide doses, according to findings presented at the National Kidney Foundation 2012 Spring Clinical Meetings.

SHPT Linked to Vitamin D Deficiency in CKD Patients

May 12, 2012

NATIONAL HARBOR, Md.—Vitamin D deficiency is strongly associated with secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD), according to data presented at the National Kidney Foundation (NKF) 2012 Spring Clinical Meetings.

Labs May Vary in iPTH Measurements

May 12, 2012

NATIONAL HARBOR, Md.—Laboratories can differ in their measurements of intact parathyroid hormone (iPTH) levels, resulting in varying treatment approaches for hemodialysis (HD) patients depending on the iPTH assay used, researchers reported at the National Kidney Foundation Spring Clinical Meetings.

Renal Ultrasound Use for CKD Patients Unchanged Despite Guidelines

May 12, 2012

NATIONAL HARBOR, Md.—Renal ultrasound use for patients with chronic kidney disease (CKD) has not changed significantly since the release of guidelines in 2002 recommending imaging studies for patients with CKD or who are at risk for it as a result of urinary stones, infections, and other factors.

PCa Patients on HD Would Benefit from Early Kidney Transplantation

May 12, 2012

NATIONAL HARBOR, Md.—Hemodialysis (HD) patients awaiting a kidney transplant must have a two-year cancer-free period immediately preceding transplantation.

Higher Alkaline Phosphatase Raises Death Risk in HD Patients

May 12, 2012

NATIONAL HARBOR, Md.—Elevated levels of serum alkaline phosphatase are associated with decreased long-term survival among hemodialysis (HD) patients, data presented at the National Kidney Foundation 2012 Spring Clinical Meetings suggest.

« Previous